A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
PRA in China Biometrics
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
Engaging Clinical Trial Sites: The Role of the Clinical Trial Liaison
The ability to engage customers is a primary driver of business success because fully engaged customers tend to purchase more and are overall more…
Center for Rare Diseases continues to engage with rare disease patient communities during COVID-19 crisis
PRA Health Sciences’ Center for Rare Diseases is committed to engaging rare disease patient communities, and providing transparency, throughout the…